Hematology
News
Survivors of childhood ALL show significant attention problems
Key clinical point: Survivors of childhood ALL who underwent CNS-directed chemotherapy show significant attention problems that impair their...
News
Blocking two targets boosted fetal hemoglobin expression
New findings related to fetal globin expression could open the door to novel therapies for adults with sickle cell disease and thalassemia.
News
Death from late effects of childhood cancer on decline
Key clinical point: Five-year survivors of childhood cancers have increased lifespans due in part to reduced rates of treatment-related late...
News
‘Considerable’ subclinical CV disease in childhood cancer survivors
Key clinical point: Screening young-adult survivors of childhood cancer revealed “considerable” subclinical cardiovascular disease. Major finding...
Conference Coverage
Expert shares ‘recipe’ for kidney stone disease
What factors are driving the rise in kidney stone disease prevalence?
News
FDA approves treatment for chemotherapy ODs, life-threatening toxicities
Conference Coverage
Video: Eltrombopag boosted standard therapy in severe, newly-diagnosed aplastic anemia
News
ASH: Prasugrel does not reduce vaso-occlusive crises in sickle cell anemia
Platelet inhibitor prasugrel has failed to show a significant reduction in the rate of vaso-occlusive crises events in children and adolescents...
Conference Coverage
VIDEO: Novel GBT440 improves blood parameters in sickle cell disease
Conference Coverage
ASH: Novel GBT440 reduces sickle cells, improves hematologic parameters
Key clinical point: A first-in class small molecule drug improved hematologic parameters and reduced sickling of red blood cells.